Last edition
News about
Biocon Acquires Manufacturing Facility of Eywa Pharma
The facility is acquired for a total consideration of US $7.7 million.
Delegation from HHS and FDA Visit Amneal Manufacturing Site in India
The visit followed the G20 Health Ministers' meeting in Gandhinagar, India, where health ministers from around the world met to discuss global health issues.
Zydus Receives Final Approval from USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg (RLD: Accutane® Capsules, 10 mg, 20 mg and 40 mg: RS: Claravis 10 mg, 20 mg, 30 mg and 40 mg).
Serum Institute of India to Launch Malaria Vaccine Soon
This was announced by Managing Director Cyrus Poonawala during a press conference.
Filament Health and Reset Pharma Enter Licensing Agreement for Botanical Psilocybin Drug Candidate
Reset Pharma will use its botanical psilocybin drug candidate, PEX010, for a phase 2 clinical trial studying demoralization syndrome.
Lonza and Vertex to Establish Manufacturing Facility for Cell Therapy in Portsmouth
The facility marks a milestone in the strategic collaboration between the two firms.
Lupin Launches Propranolol Long-Acting Capsules in Canada
Propranolol LA's launch caters to the needs of Canadian patients,reaffirming Lupin's commitment.
Strides Gets USFDA Approval for Mycophenolate Mofetil for Oral Suspension
The company has 280 cumulative ANDA filings with USFDA.
Unichem Laboratories Gets ANDA Approval for Prasugrel Tablets
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events in patients.
Ajanta Pharma Receives Final Approval for Topiramate Extended Release Capsules from USFDA
The company has received 50 final ANDA approvals, out of which 41 are commercialized.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy